indiamarketoutlook

Aurobindo Pharma : Mirror image trade potential & strategy

indiamarketoutlook Diupdate   
NSE:AUROPHARMA   AUROBINDO PHARMA
Aurobindo Pharma
Closing price 648

The chart reflects certain pattern & based on our interpretation, we might see some consolidation in prices for the next month or two.

If Aurobindo Pharma is to replicate a Mirror image pattern then a potential Short strangle strategy may be considered.

Consider selling Aurobindo Pharma

720 Call option around 20

&

580 Put option around 16

Lot size 1000

Max profit potential in strategy Rs 35000/-

Loss in strategy if Aurobindo Pharma closes above 755 or below 545 on 28-May expiry day

----------------------------------------------------------------------------------------------------------------
Cash buying may be considered in 580-615 range
----------------------------------------------------------------------------------------------------------------

Trading in Options involves risk. Understand & do follow risk management measures. Consult your financial advisor.

Take care & safe trading...!!!
Trade aktif:
720 call option opened at 21.75 made a high of 22.5 giving us a good price to sell above 20

580 Put option too made a high of 16.40 giving us our price of 16 to sell

Trade is active
Trade aktif:
Strategy Update
720 Call option sold @ 21.50 is currently at 17.8

&

580 Put option Sold @ 16 is currently at 9.50

Net so far 1000*( 37.5 - 27.3 ) = Rs 10200/-
Trade aktif:
Strategy Update
720 Call option cmp 13.35
580 Put option cmp 4.9

Net so far 1000*( 37.5 -18.25 ) = Rs 19250/-

Enjoy & have a gr8 weekend...!!! :-)
Trading ditutup secara manual:
Auro Pharma CMP 668

Strategy Update
Broader market has seen wild swings, yet Aurobindo has been fairly quiet & has stayed within a small range.

720 Call option cmp 10
580 Put option cmp 4.75

Net so far 1000*( 37.5 -14.75 ) = Rs 22750/-

The strategy has worked well & is rewarding a good profit.
Consider to book profits as per your risk appetite

Happy & safe trading...!!!

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.